Ludlow Research Issues Opinion on TriStar Wellness Solutions Based on Pending Q3 Earnings, Valuation
WESTPORT, Conn., Oct. 20, 2014 /PRNewswire/ -- TriStar Wellness Solutions®, Inc. (OTCQB: TWSI) and a leading developer and marketer of advanced medical products, announced that Ludlow Research has issued a research opinion of the Company based on strong Q3 revenue guidance, and current valuation.
Logo - http://photos.prnewswire.com/prnh/20141020/153024LOGO
Logo - http://photos.prnewswire.com/prnh/20141020/153023LOGO
Recent Earnings
For the first nine months ending September 30, 2014, the Company reported that HemCon Medical Technologies, Inc., their wholly owned subsidiary, has year-over-year revenues based on their chitosan technology platform increasing 34.60% over the same nine-month period in 2013. The Company attributed most of this growth to its continuing progress in developing existing and new sustainable revenue lines.
The Company expects revenues of its core chitosan wound care products to surpass the prior year by more than 25%, and is in line with overall business expectations for 2014.
HemCon Medical Technologies Inc., founded in 2001, develops, manufactures, and markets innovative technologies for hemostatic devices for the control of bleeding resulting from trauma or surgery. HemCon products are designed for use by military and civilian first responders as well as medical professionals in hospital and clinical settings where control of bleeding are of critical importance. HemCon is headquartered in Portland, Ore. The Company has additional commercial operations in Ireland and the Czech Republic. For more information, please visit www.hemcon.com.
Military Approval
Earlier in the year, the U.S. Department of Defense's Committee on Tactical Combat Casualty Care (CoTCCC) updated its guideline recommendations for control of severe external hemorrhage to include HemCon's ChitoGauze® PRO hemostatic chitosan-coated gauze product.
Ludlow Research issued their opinion based on the projection for stronger sales growth for their HemCon Patch® PRO product, restructure of their manufacturing, pending registration approvals for China and India, and upcoming fourth quarter revenue earnings. It is in Ludlow Research's opinion that these factors, and current market valuation, offers investors a unique entry level for value traders.
To download the full report, and access risks, disclosers, and potential outlook visit www.ludlowresearch.com/reports.html
About Ludlow Research
Ludlow Equity Research is a New York based equity research firm focused on providing our clients, and individual readers, with in-depth research coverage and opinions on the small-cap securities market. For over 14 years we have aimed to providing our subscribers a simple way of evaluating the current and potential value of small-cap stocks, and any risks that may effect those valuations going forward. Our goal is to provide traders with an easy way to make investment decisions based on current and future valuations. Ludlow Equity Research is a division of Ludlow Capital, Inc. www.ludlowresearch.com
Ludlow Research provides research coverage and host of investor awareness services for publicly traded small cap equities. If you have a company interested in additional research awareness please email us at [email protected]
About TriStar Wellness Solutions
TriStar Wellness Solutions®, Inc. (OTCQB:TWSI) is a health and wellness company that targets under-met opportunities in the OTC and professional marketplace. TriStar is the owner of HemCon Medical Technologies Inc., a company dedicated to saving lives through innovative wound care solutions. It also owns the Beaute de Maman™ brand of women's health products. Additional information is available at www.tstarwellness.com and www.beautedemaman.com.
About HemCon Medical Technologies, Inc.
HemCon Medical Technologies Inc., is a wholly owned subsidiary of TriStar Wellness Solutions®, Inc. (OTCQB:TWSI). HemCon is a developer, manufacturer, and marketer of proprietary technologies for hemostatic devices for the control of bleeding resulting from trauma or surgery. HemCon was founded in 2001 and since then has been a supplier of medical devices to the military, emergency medical and law enforcement communities. This year the company received endorsement from the Tactical Combat Casualty Care (TCCC) and is an approved supplier of bandages and hemostatic devices to government agencies and allied militaries around the world. The company this year also launched a sales force dedicated to serving the hospital and clinical markets. Additional information is available at www.hemcon.com.
Forward-Looking Statement
This press release for TriStar Wellness Solutions®, Inc. contains forward-looking statements. Generally, you can identify these statements because they use words like "anticipates," "believes," "expects," "future," "intends," "plans" and similar terms. These statements reflect only our current expectations. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy and actual results may differ materially from those we anticipated due to a number of uncertainties, many of which are unforeseen, including, among others, the risks we face as described our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements, which apply only as of the date of this press release. To the extent that such statements are not recitations of historical fact, such statements constitute forward-looking statements that, by definition, involve risks and uncertainties. In any forward-looking statement where we express an expectation or belief as to future results or events, such expectation or belief is expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the statement of expectation of belief will be accomplished.
Contact:
Simona Buergi
HemCon Medical Technologies, Inc.
Tel: (503) 245-0459
Email
Media Relations:
Melissa J. Diaz
South Street Media, Inc
Phone: (917) 937-8968
Email
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/ludlow-research-issues-opinion-on-tristar-wellness-solutions-based-on-pending-q3-earnings-valuation-586451875.html
SOURCE TriStar Wellness Solutions
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article